5 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
AMGN Amgen Inc. $200.81 $129.98B Buy
Article Searches
Top Analyst Reports for Bank of America, Merck & Netflix http://www.zacks.com/research-daily/206820/top-analyst-reports-for-bank-of-america-merck-netflix?cid=CS-ZC-FT-206820 Jan 21, 2019 - Top Analyst Reports for Bank of America, Merck & Netflix
What's in Store for Bristol-Myers (BMY) in Q4 Earnings? http://www.zacks.com/stock/news/348553/whats-in-store-for-bristol-myers-bmy-in-q4-earnings?cid=CS-ZC-FT-348553 Jan 21, 2019 - Performance of Opdivo and the recently announced acquisition of Celgene Corporation will be key areas of focus for the investors when Bristol-Myers (BMY) reports fourth-quarter results.
The Daily Biotech Pulse: Revance Common Stock Offering, Adcom Catalyst For Amgen http://feeds.benzinga.com/~r/benzinga/~3/-qf8Lb6Vq5o/the-daily-biotech-pulse-revance-common-stock-offering-adcom-catalyst- Jan 16, 2019 -

Here's a roundup of top developments in the biotech space over the last 24 hours.

Scaling The Peak

(Biotech Stocks Hitting 52-week highs Jan. 15)

read more

For Children With Cancer, Hope for New Treatments https://www.wsj.com/articles/for-children-with-cancer-hope-for-new-treatments-11547561004?mod=WSJ_GoogleNews Jan 15, 2019 - A new law requiring pharmaceuticals companies to test cancer drugs on children as well as adults is raising hopes of more therapies.
Why AbbVie Believes In Life After (Humira's) Death https://seekingalpha.com/article/4233472-abbvie-believes-life-humiras-death?source=feed_sector_healthcare Jan 15, 2019 - ABBV has been mired in a bear market, in large part due to worse-than-expected competition to Humira from biosimilars in the EU.U.S. biosimilars to Humira will enter in 2023, though a competitor is tr

Pages: 1

Page 1

Related Companies

Name Exchange Price Mkt Cap
GILD Gilead Sciences, Inc. NASDAQ $72.78 $94.35B
BIIB Biogen Inc. NASDAQ $334.44 $67.37B
SGEN Seattle Genetics, Inc. NASDAQ $76.15 $12.09B
NBIX Neurocrine Biosciences, Inc. NASDAQ $117.38 $10.62B
QGEN Qiagen N.V. NASDAQ $37.42 $8.5B
Sector: Health Care > Industry: Biotechnology: Biological Products (No Diagnostic Substances)
DeepLinks for Amgen
AMGN - Google Finance https://www.google.com/finance?q=AMGN Industry related info and international coverage Summary News
AMGN - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=AMGN Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options